Cost containment in hypertension management is feasible without compromising care by avoiding unnecessary diagnostic tests and utilizing cost-effective initial therapies.
No takes yet. Share an insight, caveat, or question.
May guide cost-conscious hypertension care; leaves open prospective validation of outcomes.
M. Moser (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: